Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Number of holders
-
39
-
Total principal
-
402M
-
Principal change
-
+11.9M
-
Total reported value, excl. options
-
$398M
-
Value change
-
+$12M
-
Number of buys
-
12
-
Number of sells
-
-15
-
Price
-
$0.99
Significant Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q4 2021
37 filings reported holding 868459AD0 - SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q4 2021.
SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 has 39 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $402M of principal
.
Largest 10 bondholders include TENOR CAPITAL MANAGEMENT Co., L.P. ($74M of principal), Radcliffe Capital Management, L.P. ($69M of principal), Opti Capital Management, LP ($45.4M of principal), DeepCurrents Investment Group LLC ($33.2M of principal), JPMORGAN CHASE & CO ($22.1M of principal), OAKTREE CAPITAL MANAGEMENT LP ($19.9M of principal), AVIVA PLC ($17.3M of principal), Invesco Ltd. ($14.6M of principal), Polar Capital Holdings Plc ($13.5M of principal), and Jefferies Group LLC ($12.7M of principal).
This table shows the top 39 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.